• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Denis Chem Lab Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 13342.0
  • ISIN : INE051G01012
98.95 0 (0.20%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    97.10

  • Today’s High

    99.64

  • Open

    98.00

  • Perv Close

    98.75

  • 52W Low

    87.99

  • 52W High

    193.00

Key Indicators

  • P/E(TTM)

    17.00

  • Mar.Cap (₹Cr.)

    137.31

  • Div & Yield %

    1.52

  • Book Value(₹)

    61.33

  • Debt-Equity Ratio

    0.20

  • AGM Date

    01-Aug-2025

  • EPS

    5.82

  • P/E Ratio

    17.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    137.31

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    13.88

  • BV (₹)

    61.30

  • Sales( ₹ in Cr.)

    173.30

  • NP (in Cr.)

    8.08

  • NP Var(%)

    -28.0

  • Div%

    15.0

  • CPS (₹)

    10.80

  • EPS (₹)

    5.80

  • Traded Value (₹ in Lakhs)

    137.31

  • 52 Week High

    193.00

  • 52 Week Low

    87.99

  • Price BSE

    99.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    137.31

  • P/C Ratio

    9.20

  • P/E Ratio

    17.00

  • Price Vs.BV

    5.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 167.82 160.85 136.56 109.32 136.15 124.14
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 167.82 160.85 136.56 109.32 136.15 124.14
Other Income 1.39 0.59 1.05 0.35 0.28 1.66
Stock Adjustments 1.01 -1.05 -0.03 0.36 1.31 -0.36
Total Income 170.22 160.39 137.58 110.03 137.74 125.44
EXPENDITURE :            
Raw Materials 87.88 83.41 72.32 55.80 62.88 60.82
Power and Fuel Cost 10.59 10.02 8.73 7.22 9.56 8.39
Employee Cost 14.39 13.03 11.74 10.59 12.20 12.46
Other Manufacturing Expenses 4.52 4.88 3.27 2.85 4.54 2.76
Selling and Administration Expenses 26.46 24.99 22.79 19.20 32.02 24.07
Miscellaneous Expenses 3.76 4.70 3.33 3.77 1.26 1.40
Employee Benefit Expenses 14.39 13.03 11.74 10.59 12.20 12.46
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 147.61 141.02 122.18 99.43 122.46 109.89
Operating Profit 22.62 19.37 15.40 10.60 15.28 15.53
Interest 0.54 0.64 0.76 1.55 2.89 3.25
Gross Profit 22.08 18.73 14.64 9.05 12.39 12.28
Depreciation 6.95 7.82 5.76 5.96 6.66 6.36
Profit Before Tax 15.13 10.91 8.88 3.09 5.73 5.92
Current Tax 4.87 3.65 2.15 1.17 1.22 1.29
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.89 -0.60 0.47 -0.34 0.29 -1.72
Reported Net Profit 11.16 7.86 6.26 2.26 4.21 6.35
Extraordinary Items 0.00 0.00 0.02 0.00 0.00 0.81
Adjusted Net Profit 11.16 7.86 6.24 2.26 4.21 5.54
Adjustment below Net Profit -0.28 0.03 -0.28 0.15 -0.20 0.17
P & L Balance brought forward 26.19 20.38 15.43 13.01 10.38 3.86
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 2.78 2.08 1.04 0.00 1.39 0.00
P & L Balance carried down 34.29 26.19 20.38 15.43 13.01 10.38
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 25.00 20.00 15.00 7.50 0.00 10.00
Dividend Per Share(Rs) 2.50 2.00 1.50 0.75 0.00 1.00
Earnings Per Share-Unit Curr 8.04 5.66 4.51 1.63 3.04 4.58
Earnings Per Share(Adj)-Unit Curr 8.04 5.66 4.51 1.63 3.04 4.58
Book Value 57.91 52.08 47.89 44.32 42.58 40.69
Book Value(Adj)-Unit Curr 57.91 52.08 47.89 44.32 42.58 40.69

Shareholding Pattern

  • Promoter Group

    38.98%

  • Public Share Holding

    61.02%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,409,237 38.98 5,409,237 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,409,237 38.98 5,409,237 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,000 0.01 1,000 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,000 0.01 1,000 1
2] Non Institution
Bodies Corporate 1,394,254 10.05 1,394,254 29
Clearing Members 6 0.00 6 1
Directors of their Relatives 62,656 0.45 62,656 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 73,442 0.53 73,242 93
Foreign Non Institution Other 2,877,774 20.74 2,877,774 1
Hindu Undivided Families 133,281 0.96 133,281 206
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,460,533 10.53 1,460,533 5
Individuals holding nominal share capital up to Rs. 1 lakh 2,455,300 17.69 2,246,632 6,881
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 274 0.00 224 2
Sub Total 8,466,431 61.01 8,257,513 7,223
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 13,876,668 100.00 13,667,750 7,227

Company Background

Denis Chem Lab LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Denis Chem Lab Ltd
  • BSE Code : 13342.0
  • ISIN : INE051G01012

  • Incorporation Year

    1980

  • Registered Office

    Block No 457 Kalol Taluka
    Chhatral, Gandhinagar,
    Gujarat-382729

  • Telephone

    91-2764-233596/233613

  • FAX

    91-2764-233896

  • Chairman

    Dinesh B Patel

  • Managing Director

    Himanshu C Patel

  • Company Secretary

    Anal Desai

  • Auditor

    Shah & Shah Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Link Intime India Pvt Ltd
    5th Floor 506 to 508,
    ABC-1 Off C.G Road ,Ellisbridge
    Mumbai - Ahmedabad-380006

Denis Chem Lab Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Denis Chem Lab 98.95 169.21 167.82 17.00 20.07
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10